• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎的生存、死亡率及流行风险状况:伊朗戈勒斯坦省的一项基于人群的研究

Survival, mortality and epidemic risk status of COVID-19: a population-based Study in Golestan province, Iran.

作者信息

Kashiri Fatemeh, Sarbakhsh Parvin, Mohammadpoorasl Asghar, Seyedghasemi Navisa Sadat, Bagheri Ali, Akbari Hossein

机构信息

Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Biostatistics and Epidemiology, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Arch Public Health. 2024 Jul 8;82(1):105. doi: 10.1186/s13690-024-01330-4.

DOI:10.1186/s13690-024-01330-4
PMID:38978085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11229216/
Abstract

BACKGROUND

Appreciating the various dimensions of the coronavirus disease 2019 (COVID-19) pandemic can improve health systems and prepare them to deal better with future pandemics and public health events. This study was conducted to investigate the association between the survival of hospitalized patients with COVID-19 and the epidemic risk stratification of the disease in Golestan province, Iran.

METHODS

In this study, all patients with COVID-19 who were hospitalized in the hospitals of Golestan province of Iran from February 20, 2020, to December 19, 2022, and were registered in the Medical Care Monitoring Center (MCMC) system (85,885 individuals) were examined.The community's epidemic risk status (ERS) was determined based on the daily incidence statistics of COVID-19. The survival distribution and compare Survival in different subgroups was investigated using Kaplan-Meier and log-rank test and association between the survival and ERS by multiple Cox regression modeling.

RESULTS

Out of 68,983 individuals whose data were correctly recorded, the mean age was 49 (SD = 23.98) years, and 52.8% were women. In total, 11.1% eventually died. The length of hospital stay was varying significantly with age, gender, ERS, underlying diseases, and COVID-19 severity (P < 0.001 for all). The adjusted hazard ratio of death for the ERS at medium, high, and very high-risk status compared to the low-risk status increased by 19%, 26%, and 56%, respectively (P < 0.001 for all).

CONCLUSIONS

Enhancing preparedness, facilitating rapid rises in hospital capacities, and developing backup healthcare capacities can prevent excessive hospital referrals during health crises and further deaths.

摘要

背景

了解2019冠状病毒病(COVID-19)大流行的各个方面有助于改善卫生系统,并使其做好更好应对未来大流行和公共卫生事件的准备。本研究旨在调查伊朗戈勒斯坦省COVID-19住院患者的生存情况与该疾病的流行风险分层之间的关联。

方法

在本研究中,对2020年2月20日至2022年12月19日期间在伊朗戈勒斯坦省医院住院并登记在医疗保健监测中心(MCMC)系统中的所有COVID-19患者(85,885人)进行了检查。根据COVID-19的每日发病率统计确定社区的流行风险状况(ERS)。使用Kaplan-Meier法和对数秩检验研究生存分布并比较不同亚组的生存率,并通过多因素Cox回归模型研究生存率与ERS之间的关联。

结果

在数据记录正确的68,983人中,平均年龄为49岁(标准差=23.98),女性占52.8%。共有11.1%的患者最终死亡。住院时间在年龄、性别、ERS、基础疾病和COVID-19严重程度方面存在显著差异(所有P<0.001)。与低风险状态相比,中、高和非常高风险状态的ERS的调整后死亡风险比分别增加了19%、26%和56%(所有P<0.001)。

结论

加强准备工作、促进医院容量的快速增加以及发展备用医疗能力可以防止在健康危机期间出现过多的医院转诊和进一步的死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/0ea8bc20f12f/13690_2024_1330_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/728c7720c00a/13690_2024_1330_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/add2b2addd1c/13690_2024_1330_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/0ea8bc20f12f/13690_2024_1330_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/728c7720c00a/13690_2024_1330_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/add2b2addd1c/13690_2024_1330_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a57c/11229216/0ea8bc20f12f/13690_2024_1330_Fig3_HTML.jpg

相似文献

1
Survival, mortality and epidemic risk status of COVID-19: a population-based Study in Golestan province, Iran.新型冠状病毒肺炎的生存、死亡率及流行风险状况:伊朗戈勒斯坦省的一项基于人群的研究
Arch Public Health. 2024 Jul 8;82(1):105. doi: 10.1186/s13690-024-01330-4.
2
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
3
Survival Analysis of Hospital Length of Stay of COVID-19 Patients in Ilam Province, Iran: A Retrospective Cross-Sectional Study.伊朗伊拉姆省新冠肺炎患者住院时间的生存分析:一项回顾性横断面研究
J Clin Med. 2023 Oct 23;12(20):6678. doi: 10.3390/jcm12206678.
4
Spatial modeling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020).伊朗2020年2月19日至6月14日期间冠状病毒(COVID-19)的空间建模、风险制图、变化检测及疫情趋势分析
Int J Infect Dis. 2020 Sep;98:90-108. doi: 10.1016/j.ijid.2020.06.058. Epub 2020 Jun 20.
5
Epidemiological and clinical characteristics of the COVID-19 epidemic and associated factors for mortality in Golestan province, Iran: a retrospective cohort study.伊朗戈勒斯坦省 COVID-19 疫情的流行病学和临床特征及与死亡率相关的因素:一项回顾性队列研究。
J Prev Med Hyg. 2021 Jul 30;62(2):E298-E304. doi: 10.15167/2421-4248/jpmh2021.62.2.1910. eCollection 2021 Jun.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.伊朗 2019 冠状病毒病(COVID-19)患者的流行病学特征:一项单中心研究。
J Clin Virol. 2020 Jun;127:104378. doi: 10.1016/j.jcv.2020.104378. Epub 2020 Apr 21.
9
Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors.在大流行的两年中,伊朗健康保险组织(IHIO)覆盖的近 100 万例住院 COVID-19 患者的病死率和住院时间模式:相关因素分析。
PLoS One. 2024 Feb 23;19(2):e0298604. doi: 10.1371/journal.pone.0298604. eCollection 2024.
10
Recent advances in oesophageal diseases.食管疾病的最新进展
Gastroenterol Hepatol Bed Bench. 2014 Summer;7(3):186-9.

本文引用的文献

1
The Effects of Covid-19 on Financial-Economic and Performance Efficiency of Hospitals.新冠疫情对医院财务经济及绩效效率的影响
Med J Islam Repub Iran. 2023 Apr 25;37:43. doi: 10.47176/mjiri.37.43. eCollection 2023.
2
Identifying age- and sex-specific COVID-19 mortality trends over time in six countries.分析六个国家 COVID-19 死亡率随时间变化的年龄和性别特异性趋势。
Int J Infect Dis. 2023 Mar;128:32-40. doi: 10.1016/j.ijid.2022.12.004. Epub 2022 Dec 10.
3
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.
变异株和疫苗接种对 COVID-19 住院患者病死率和资源利用的影响。
BMC Infect Dis. 2022 Aug 22;22(1):702. doi: 10.1186/s12879-022-07657-z.
4
Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countries.性别差异在 2019 年冠状病毒病死亡率与其他死因比较:来自 63 个国家的全人群数据分析。
Eur J Epidemiol. 2022 Aug;37(8):797-806. doi: 10.1007/s10654-022-00866-5. Epub 2022 Jun 23.
5
Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran.合并症对COVID-19住院患者死亡率的影响:来自伊朗的经验。
J Educ Health Promot. 2021 Dec 31;10:460. doi: 10.4103/jehp.jehp_1589_20. eCollection 2021.
6
Impact of varying wave periods of COVID-19 on in-hospital mortality and length of stay for admission through emergency department: A territory-wide observational cohort study.新冠疫情不同波幅对因急症入院的住院死亡率和住院时间的影响:全港范围观察性队列研究。
Influenza Other Respir Viruses. 2022 Mar;16(2):193-203. doi: 10.1111/irv.12919. Epub 2021 Oct 13.
7
Mortality in hospitalized COVID-19 patients was associated with the COVID-19 admission rate during the first year of the pandemic in Sweden.在瑞典大流行的第一年,住院 COVID-19 患者的死亡率与 COVID-19 入院率相关。
Infect Dis (Lond). 2022 Feb;54(2):145-151. doi: 10.1080/23744235.2021.1983643. Epub 2021 Oct 6.
8
Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.与 COVID-19 重症患者死亡率相关的因素:系统评价和荟萃分析。
Anaesthesia. 2021 Sep;76(9):1224-1232. doi: 10.1111/anae.15532. Epub 2021 Jun 29.
9
The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020.自 2020 年 5 月以来,全球 COVID-19 的病死率一直在下降。
Am J Trop Med Hyg. 2021 Apr 21;104(6):2176-2184. doi: 10.4269/ajtmh.20-1496.
10
Hospital load and increased COVID-19 related mortality in Israel.以色列的医院负担与新冠病毒相关死亡率上升
Nat Commun. 2021 Mar 26;12(1):1904. doi: 10.1038/s41467-021-22214-z.